1Ajello A, Freni MA, Spadaro A, et al. Ten year follow-up of patients with chronic hepatitis C treated with interferon. Hepatogastroenterology, 1999, 46: 2447-2450.
2Reddy KR, Wright TL, Pockros PJ, et al. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology, 2001, 33: 433-438.
3Enomoto M, Nishiguchi S, Tanaka M, et al. Dynamics of hepatitis C virus monitored by real-time quantitative polymerase chain reaction during first 2 weeks of IFN-beta treatment are predictive of long-term therapeutic response. J Interferon Cytokine Res, 2002, 22: 389-395.
4Nakamuta M, Fukutomi T, Shimohashi N, et al. Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response. J Gastroenterol Hepatol, 2001, 16: 29-33.
5Jessner W, Stauber R, Hackl F, et al. Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection. J Viral Hepat, 2003, 10: 37-42.
